For those patients with higher risk for metastasis and worse survival stratified by the combination of PD-L1 and EBV status, more intensive anti-tumor treatment may necessary to reduce the incidence of metastasis and recurrence, further to improve patients’ survival. Here, CD274 is linked to neoplasm.